BRPI0606606A2 - composições estáveis contendo prostaglandina - Google Patents
composições estáveis contendo prostaglandinaInfo
- Publication number
- BRPI0606606A2 BRPI0606606A2 BRPI0606606-2A BRPI0606606A BRPI0606606A2 BR PI0606606 A2 BRPI0606606 A2 BR PI0606606A2 BR PI0606606 A BRPI0606606 A BR PI0606606A BR PI0606606 A2 BRPI0606606 A2 BR PI0606606A2
- Authority
- BR
- Brazil
- Prior art keywords
- prostaglandin
- containing compositions
- acid ester
- chemical stability
- alkanoic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
COMPOSIçõES ESTáVEIS CONTENDO PROSTAGLANDINA. A presente invenção se refere à composição farmacêutica contendo uma prostaglandina e um éster de ácido alcanóico de um sorbitol polietoxilado em uma quantidade eficaz para intensificar a estabilidade química da prostaglandina e o uso da mesma para o tratamento de condições oftálmicas. Também divulgados são métodos para intensificação da estabilidade química de uma composição contendo prostaglandina através de uso de um éster de ácido alcanóico de um sorbitol polietoxilado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0501192.9A GB0501192D0 (en) | 2005-01-20 | 2005-01-20 | Stable prostaglandin-containing compositions |
PCT/US2006/001626 WO2006078659A2 (en) | 2005-01-20 | 2006-01-18 | Stable prostaglandin-containing compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0606606A2 true BRPI0606606A2 (pt) | 2009-07-07 |
Family
ID=34259405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0606606-2A BRPI0606606A2 (pt) | 2005-01-20 | 2006-01-18 | composições estáveis contendo prostaglandina |
Country Status (16)
Country | Link |
---|---|
US (2) | US8084501B2 (pt) |
EP (1) | EP1843744A2 (pt) |
JP (2) | JP2008528490A (pt) |
KR (1) | KR20070094793A (pt) |
CN (1) | CN101106973A (pt) |
AU (1) | AU2006206649B2 (pt) |
BR (1) | BRPI0606606A2 (pt) |
CA (1) | CA2595237A1 (pt) |
CZ (1) | CZ2007555A3 (pt) |
GB (1) | GB0501192D0 (pt) |
IL (1) | IL184111A0 (pt) |
IS (1) | IS8665A (pt) |
NO (1) | NO20073699L (pt) |
NZ (1) | NZ556117A (pt) |
WO (1) | WO2006078659A2 (pt) |
ZA (1) | ZA200705428B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI394564B (zh) * | 2006-09-21 | 2013-05-01 | Alcon Res Ltd | 自行保存型水性藥學組成物 |
WO2008073748A1 (en) | 2006-12-08 | 2008-06-19 | University Of Rochester | Expansion of hematopoietic stem cells |
CN101621997B (zh) | 2007-01-26 | 2013-05-08 | 株式会社宝丽制药 | 医药组合物 |
US20100120908A1 (en) * | 2007-02-07 | 2010-05-13 | Teika Pharmaceutical Co., Ltd | Eye drop preparation comprising latanoprost |
JP2008247828A (ja) * | 2007-03-30 | 2008-10-16 | Wakamoto Pharmaceut Co Ltd | ラタノプロストを含有する水性医薬組成物。 |
ES2394130T3 (es) | 2007-11-30 | 2013-01-22 | Toltec Pharmaceuticals, Llc | Composiciones y métodos para tratar infecciones vaginales y biopelículas vaginales patógenas |
TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
EP2328574A1 (en) * | 2008-08-05 | 2011-06-08 | University College Cork-National University of Ireland, Cork | Treatment of retinal degeneration |
US20100087540A1 (en) * | 2008-10-07 | 2010-04-08 | R-Tech Ueno, Ltd. | Pharmaceutical composition |
US20120232139A1 (en) * | 2009-09-01 | 2012-09-13 | Ryuji Ueno | Composition for ocular topical administration treatment ocular hypertension and glaucoma |
AU2010314863A1 (en) * | 2009-11-09 | 2012-06-14 | Allergan, Inc. | Compositions for enhancing hair growth |
TWI478730B (zh) * | 2009-12-03 | 2015-04-01 | Alcon Res Ltd | 眼科乳劑 |
WO2012141334A1 (en) * | 2011-04-12 | 2012-10-18 | R-Tech Ueno, Ltd. | Aqueous ophthalmic composition |
DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
CN104208015A (zh) * | 2013-05-29 | 2014-12-17 | 天津金耀集团有限公司 | 含有曲伏***素和防腐剂的眼部制剂 |
EP3103439B1 (en) * | 2015-06-09 | 2019-08-07 | MEDproject Pharma-Entwicklungs- und Vertriebsgesellschaft mbH | Drippable ophthalmic bimatoprost gel |
EP3643297A4 (en) | 2017-06-22 | 2021-03-17 | Yonsung Fine Chemical Co., Ltd. | OPHTHALMIC COMPOSITION FOR GLUCOMA TREATMENT |
EP4331600A1 (en) * | 2021-04-30 | 2024-03-06 | Innovent Biologics (Suzhou) Co., Ltd. | Oxm3 storage agent, oxm3 preparation, and preparation method |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1366215A (en) * | 1916-08-05 | 1921-01-18 | Vaporackumulator Ab | Supplementary power plant for electric centrals |
US5165918A (en) * | 1988-06-28 | 1992-11-24 | Ciba-Geigy Corporation | Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same |
ES2067864T3 (es) * | 1990-05-22 | 1995-04-01 | R Tech Ueno Ltd | Tratamiento de la hipertension ocular con una combinacion sinergica para administracion ocular. |
CA2086874E (en) * | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
US5972991A (en) * | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
AU665287B2 (en) * | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
US5545665A (en) | 1993-12-28 | 1996-08-13 | Allergan | Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US6011062A (en) * | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
WO1997023225A1 (en) * | 1995-12-22 | 1997-07-03 | Alcon Laboratories, Inc. | Combinations of dp and fp type prostaglandins for lowering iop |
AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
SE9702681D0 (sv) | 1997-07-10 | 1997-07-10 | Pharmacia & Upjohn Ab | Method and composition for treatment of impotence |
SE9702706D0 (sv) | 1997-07-11 | 1997-07-11 | Pharmacia & Upjohn Ab | Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
AU9305898A (en) | 1997-09-09 | 1999-03-29 | Procter & Gamble Company, The | A process for making prostaglandin f analogs |
US6646001B2 (en) * | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
WO2000020386A1 (en) | 1998-10-05 | 2000-04-13 | Alcon Laboratories, Inc. | Stannane synthesis of prostanoids |
US6417228B1 (en) * | 1998-11-02 | 2002-07-09 | Alcon Manufacturing, Ltd.. | 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
SE9900025D0 (sv) | 1999-01-08 | 1999-01-08 | Synphora Ab | Method and composition for treatment of female sexual dysfunction |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
JP3876355B2 (ja) * | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
DK1321144T3 (da) * | 2000-09-13 | 2011-03-07 | Santen Pharmaceutical Co Ltd | Øjendråber |
AR035541A1 (es) * | 2000-11-13 | 2004-06-16 | Pharmacia Ab | Un metodo de tratamiento para pacientes que sufren de glaucoma severo o necesitan una reduccion de la presion intraocular (pio) y el uso de una combinacion de agentes reductores de la pio |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
US7351404B2 (en) * | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
NO317079B1 (no) * | 2002-08-02 | 2004-08-02 | Maritime Hydraulics As | Stigerorstrekkanordning |
US6864282B2 (en) * | 2002-08-05 | 2005-03-08 | Allergan, Inc. | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
US20040076678A1 (en) * | 2002-08-21 | 2004-04-22 | Sucampo Ag | Opthalmic solution |
KR101253941B1 (ko) | 2002-09-09 | 2013-04-16 | 산텐 세이야꾸 가부시키가이샤 | 라타노프로스트를 유효 성분으로 하는 투명한 점안액 |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
-
2005
- 2005-01-20 GB GBGB0501192.9A patent/GB0501192D0/en not_active Ceased
-
2006
- 2006-01-18 KR KR1020077016516A patent/KR20070094793A/ko not_active Application Discontinuation
- 2006-01-18 EP EP06718670A patent/EP1843744A2/en not_active Withdrawn
- 2006-01-18 CA CA002595237A patent/CA2595237A1/en not_active Abandoned
- 2006-01-18 JP JP2007552216A patent/JP2008528490A/ja active Pending
- 2006-01-18 WO PCT/US2006/001626 patent/WO2006078659A2/en active Application Filing
- 2006-01-18 BR BRPI0606606-2A patent/BRPI0606606A2/pt not_active IP Right Cessation
- 2006-01-18 AU AU2006206649A patent/AU2006206649B2/en not_active Ceased
- 2006-01-18 CN CNA2006800023897A patent/CN101106973A/zh active Pending
- 2006-01-18 NZ NZ556117A patent/NZ556117A/en not_active IP Right Cessation
- 2006-01-20 US US11/336,115 patent/US8084501B2/en not_active Expired - Fee Related
-
2007
- 2007-06-21 IL IL184111A patent/IL184111A0/en unknown
- 2007-07-03 ZA ZA200705428A patent/ZA200705428B/xx unknown
- 2007-07-17 NO NO20073699A patent/NO20073699L/no not_active Application Discontinuation
- 2007-08-02 IS IS8665A patent/IS8665A/is unknown
- 2007-08-16 CZ CZ20070555A patent/CZ2007555A3/cs unknown
-
2011
- 2011-11-17 US US13/298,400 patent/US20120065258A1/en not_active Abandoned
-
2012
- 2012-12-27 JP JP2012286362A patent/JP2013056948A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2006206649B2 (en) | 2010-05-27 |
CN101106973A (zh) | 2008-01-16 |
WO2006078659A3 (en) | 2006-11-16 |
WO2006078659A2 (en) | 2006-07-27 |
ZA200705428B (en) | 2008-09-25 |
EP1843744A2 (en) | 2007-10-17 |
US20060270735A1 (en) | 2006-11-30 |
AU2006206649A1 (en) | 2006-07-27 |
JP2013056948A (ja) | 2013-03-28 |
JP2008528490A (ja) | 2008-07-31 |
KR20070094793A (ko) | 2007-09-21 |
WO2006078659A8 (en) | 2007-08-30 |
IS8665A (is) | 2007-08-02 |
CA2595237A1 (en) | 2006-07-27 |
NO20073699L (no) | 2007-10-19 |
IL184111A0 (en) | 2007-10-31 |
CZ2007555A3 (cs) | 2007-10-10 |
US20120065258A1 (en) | 2012-03-15 |
US8084501B2 (en) | 2011-12-27 |
NZ556117A (en) | 2009-10-30 |
GB0501192D0 (en) | 2005-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0606606A2 (pt) | composições estáveis contendo prostaglandina | |
BRPI0507198A (pt) | derivados de bisariluréia | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
NI201000022A (es) | Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparación, su aplicación como medicamentos, composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met. | |
DE60325379D1 (de) | Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen | |
SV2011003903A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes | |
BRPI0721905B8 (pt) | composto inibidor de proteassoma, sua composição farmacêutica e seu uso | |
BRPI0609121B8 (pt) | 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2 | |
BR112015000578A2 (pt) | moduladores da via do complemento e usos dos mesmos | |
ECSP088891A (es) | Derivados bicíclicos como inhibidores de cetp | |
SV2008003045A (es) | Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes | |
BR112012021771A2 (pt) | métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2. | |
UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
BRPI0514766A (pt) | composições farmacêuticas | |
ECSP088414A (es) | Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria | |
UY31046A1 (es) | Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones | |
BR112015010908A2 (pt) | derivado de pirrol sulfonamida, método de preparação para o mesmo e aplicação médica do mesmo | |
BR0113989A (pt) | Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos | |
CR10479A (es) | Modulares bencimidazolicos de vr1 | |
PA8783401A1 (es) | Derivados de piperidina/piperazina | |
ECSP10010167A (es) | Composiciones oftálmicas novedosas | |
BRPI0806789B8 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
DK1797088T3 (da) | Hidtil ukendte chromen-2-on-derivater og anvendelse heraf som monoamin-neurotransmitter-genoptagelseshæmmere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A E 10A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |